
Cinzia Emilia Lavarino
Jefe de Grupo Senior
Research group
Cinzia Lavarino graduated in Biology in 1994 and obtained a Doctor of Biotechnology degree in 1999 from the Università degli Studi di Milano, Italy.
Between 1994 and 2001 she was trained at the Molecular Diagnostic Laboratory of the Instituto Nazionale dei Tumori in Milan.
Between 2001-2004 she completed a post-doctoral stay at the Department of Biochemistry, Faculty of Pharmacy, University of Barcelona.
In 2005, she joined the post-doctoral researcher at the Development Tumours Laboratory of the SJD Barcelona Children’s Hospital.
Since 2007 Cinzia Lavarino is Principal Investigator of the Translational Genomics group of the Laboratory of Developmental Tumours, included in the IRSJD Pediatric Cancer Program.
Since the beginning of 2019, Cinzia Lavarino has been a doctor in charge of healthcare activities (molecular diagnosis, prognosis prediction, molecular classification, identification of therapeutic targets, molecular monitoring of the disease) typical of the Molecular Oncology Laboratory of the Paediatric Cancer Center Barcelona (PCCB) of the SJD Barcelona Children's Hospital.
Professional network profiles
Last Publications
- Gargallo P, Bautista F, Juan-Ribelles A, Izquierdo E, Soriano A, de Rojas T, Escudero A, Lavarino C, Solano P, Hladun R, Rubio-San-Simón A, Martínez-Romera I, Calabria I, Gene-Olaciregui N, Castañeda-Heredia A, de Álava E, Pérez-Martínez A, Astigarraga I, Patiño-García A, Alonso J, Fernández-Teijeiro A, Cañete A and Moreno L Current status of precision medicine in pediatric oncology in Spain: a consensus report by the Spanish Society of Paediatric Haematology and Oncology (SEHOP). CLINICAL & TRANSLATIONAL ONCOLOGY . 24(5): 809-815.
- Gonçalves-Alves EC, Garcia-López M, Gomez-Gonzalez S, Ecker RC, Suñol M, Muñoz-Aznar O, Carcaboso AM, Mora J, Lavarino C and Mateo-Lozano S AC-265347 Inhibits Neuroblastoma Tumor Growth by Induction of Differentiation without Causing Hypocalcemia. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 23(8): 4323.
- Carvalho DM, Richardson PJ, Olaciregui N, Stankunaite R, Lavarino C, Molinari V, Corley EA, Smith DP, Ruddle R, Donovan A, Pal A, Raynaud FI, Temelso S, Mackay A, Overington JP, Phelan A, Sheppard D, Mackinnon A, Zebian B, Al-Sarraj S, Merve A, Pryce J, Grill J, Hubank M, Cruz-Martínez O, Morales-La Madrid A, Mueller S, Carcaboso AM, Carceller F and Jones C Repurposing Vandetanib plus Everolimus for the Treatment of ACVR1-Mutant Diffuse Intrinsic Pontine Glioma. CANCER DISCOVERY . 12(2): 416-431.
Projects
- Project name:
- SEHOP-PENCIL study - Personalised mEdiciNe for Cancer in chILdren in Spain
- Leader
- Cinzia Emilia Lavarino
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- PMP21/00075
- Starting - finishing date:
- 2022 - 2025
- Project name:
- Desarrollo de clasificadores epigenéticos para el Cáncer Pediátrico (ECPC)
- Leader
- Cinzia Emilia Lavarino
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- PI20/00519
- Starting - finishing date:
- 2021 - 2023
- Project name:
- Platform of Epigenetic Classifiers for Childhood CAncer (PECA)
- Leader
- Cinzia Emilia Lavarino
- Funding entities:
- Fundació La Marató de TV3
- Code
- 201921-30
- Starting - finishing date:
- 2020 - 2023